Abstract
To assess the hemodynamic properties of the new inhalational anesthetic sevoflurane, 22 dogs were chronically instrumented for measurement of heart rate, aortic, left ventricular and left atrial pressures, cardiac output, and coronary blood flow. Dogs were randomly assigned to two groups, receiving either 1.2 and 2 MAC of sevoflurane produced an increase in heart rate (+60 ± 12% and +54 ± 9%, respectively), dose-dependent aortic hypotension (−22 ± 4% and −38 ± 4%, respectively), systemic vasodilation (−22 ± 5% and −19 ± 5%, respectively), dose-dependent decrease in stroke volume (−31 ± 6% and −48 ± 4%, respectively), and left ventricular dP/dt (−40 ± 4% and −61 ± 10%, respectively). Cardiac output decreased only at 2 MAC (−17 ± 6%). Finally, coronary blood flow increased at 1.2 MAC of sevoflurane (+29 ± 8%). Except for heart rate, sevoflurane and isoflurane produced similar effects. At 1.2 MAC, sevoflurane produced a grater increase in heart rate than isoflurane (+60 ± 12% vs. +33 ± 9%). The authors conclude that, except for heart rate, the effects of sevoflurance on cardiac function and coronary blood flow are almost identical to those induced by isoflurance in the chronically instrumented dog.